Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 1
1987 3
1988 2
1990 6
1991 10
1993 7
1994 5
1995 3
1996 1
1997 1
1999 2
2004 1
2006 4
2007 5
2008 3
2009 1
2010 2
2011 4
2012 1
2013 6
2014 7
2015 6
2016 5
2017 6
2018 2
2019 4
2020 5
2021 11
2022 7
2023 1
Text availability
Article attribute
Article type
Publication date

Search Results

115 results
Results by year
Filters applied: . Clear all
Page 1
Pulmonary function testing during SARS-CoV-2: An ANZSRS/TSANZ position statement.
Borg BM, Osadnik C, Adam K, Chapman DG, Farrow CE, Glavas V, Hancock K, Lanteri CJ, Morris EG, Romeo N, Schneider-Futschik EK, Selvadurai H. Borg BM, et al. Among authors: lanteri cj. Respirology. 2022 Sep;27(9):688-719. doi: 10.1111/resp.14340. Epub 2022 Aug 10. Respirology. 2022. PMID: 35981737 Free PMC article. Review.
Cutaneous clues to clinch a diagnosis amidst pandemic.
Nohrenberg M, Shamdasani P, Sweeney D, Lanteri C, Hoi A. Nohrenberg M, et al. Among authors: lanteri c. Intern Med J. 2022 Oct;52(10):1836-1837. doi: 10.1111/imj.15346. Epub 2022 Aug 22. Intern Med J. 2022. PMID: 35993763 No abstract available.
Recent advances in malaria drug discovery.
Lanteri CA, Johnson JD, Waters NC. Lanteri CA, et al. Recent Pat Antiinfect Drug Discov. 2007 Jun;2(2):95-114. doi: 10.2174/157489107780832640. Recent Pat Antiinfect Drug Discov. 2007. PMID: 18221166 Review.
Durability of SARS-CoV-2-Specific T-Cell Responses at 12 Months Postinfection.
Lu Z, Laing ED, Pena DaMata J, Pohida K, Tso MS, Samuels EC, Epsi NJ, Dorjbal B, Lake C, Richard SA, Maves RC, Lindholm DA, Rozman JS, English C, Huprikar N, Mende K, Colombo RE, Colombo CJ, Broder CC, Ganesan A, Lanteri CA, Agan BK, Tribble D, Simons MP, Dalgard CL, Blair PW, Chenoweth J, Pollett SD, Snow AL, Burgess TH, Malloy AMW; EPICC COVID-19 Cohort Study Group. Lu Z, et al. Among authors: lanteri ca. J Infect Dis. 2021 Dec 15;224(12):2010-2019. doi: 10.1093/infdis/jiab543. J Infect Dis. 2021. PMID: 34673956 Free PMC article.
Report of the National Institutes of Health SARS-CoV-2 Antiviral Therapeutics Summit.
Hall MD, Anderson JM, Anderson A, Baker D, Bradner J, Brimacombe KR, Campbell EA, Corbett KS, Carter K, Cherry S, Chiang L, Cihlar T, de Wit E, Denison M, Disney M, Fletcher CV, Ford-Scheimer SL, Götte M, Grossman AC, Hayden FG, Hazuda DJ, Lanteri CA, Marston H, Mesecar AD, Moore S, Nwankwo JO, O'Rear J, Painter G, Singh Saikatendu K, Schiffer CA, Sheahan TP, Shi PY, Smyth HD, Sofia MJ, Weetall M, Weller SK, Whitley R, Fauci AS, Austin CP, Collins FS, Conley AJ, Davis MI. Hall MD, et al. Among authors: lanteri ca. J Infect Dis. 2021 Jul 15;224(Supplement_1):S1-S21. doi: 10.1093/infdis/jiab305. J Infect Dis. 2021. PMID: 34111271 Free PMC article.
Distinct blood inflammatory biomarker clusters stratify host phenotypes during the middle phase of COVID-19.
Blair PW, Brandsma J, Chenoweth J, Richard SA, Epsi NJ, Mehta R, Striegel D, Clemens EG, Alharthi S, Lindholm DA, Maves RC, Larson DT, Mende K, Colombo RE, Ganesan A, Lalani T, Colombo CJ, Malloy AA, Snow AL, Schully KL, Lanteri C, Simons MP, Dumler JS, Tribble D, Burgess T, Pollett S, Agan BK, Clark DV; EPICC COVID-19 Cohort Study Group. Blair PW, et al. Among authors: lanteri c. Sci Rep. 2022 Dec 28;12(1):22471. doi: 10.1038/s41598-022-26965-7. Sci Rep. 2022. PMID: 36577783 Free PMC article.
115 results